Abstract:Shufeng Liang, 1, 2 Xin Tian, 3 Chunyan Wang 4 1 Department of Molecular Biology, Shanxi Province Cancer Hospital/Shanxi Hospital, Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, People's Republic of China; 2 Institute of Environmental Sciences, Shanxi University, Taiyuan, People's Republic of China; 3 State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, People's Republic of China; 4 Department of Transfusion, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, People's Republic of China Correspondence: Xin Tian; Chunyan Wang, Department of Transfusion, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, No 3 Zhigongxin Street, Xinghualing, Taiyuan, Shanxi, People's Republic of China, Tel +86 15110313926, Email ; Excessive reactive oxygen species (ROS) may generate deleterious effects on biomolecules, such as DNA damage, protein oxidation and lipid peroxidation, causing cell and tissue damage and eventually leading to the pathogenesis of diseases, such as neurodegenerative diseases, ischemia/reperfusion ((I/R)) injury, and inflammatory diseases. Therefore, the modulation of ROS can be an efficient means to relieve the aforementioned diseases. Several studies have verified that antioxidants such as Mitoquinone (a mitochondrial-targeted coenzyme Q10 derivative) can scavenge ROS and attenuate related diseases. Nanozymes, defined as nanomaterials with intrinsic enzyme-like properties that also possess antioxidant properties, are hence expected to be promising alternatives for the treatment of ROS-related diseases. This review introduces the types of nanozymes with inherent antioxidant activities, elaborates on various strategies (eg, controlling the size or shape of nanozymes, regulating the composition of nanozymes and environmental factors) for modulating their catalytic activities, and summarizes their performances in treating ROS-induced diseases. Keywords: nanozymes, enzyme-mimic, oxidative stress, antioxidant, ROS-related diseases Reactive oxygen species (ROS) contain various reactive molecules and free radicals (species with unpaired electrons) derived from molecular oxygen, such as hydrogen peroxide (H 2 O 2 ), superoxide (O 2 ·− ) and hydroxyl radicals ( · OH). 1–3 ROS are produced by a cell converting oxygen into oxygen radicals during physiological processes in biological systems and play roles as signaling molecules in cells, including activating cell signaling cascades, inducing apoptosis, and influencing gene expression. 4–7 However, oxidative stress occurs when ROS generation increases or antioxidant defense systems become weaker or both, which means unquenched ROS may trigger further reactions. 5,8,9 In turn, oxidative stress destroys biomacromolecules and plays a part in a series of pathologies, including neurodegeneration, inflammation, atherosclerosis, diabetes, and aging. 4,10–12 As massive ROS production and associated oxidative damage are also identified as important causative factors for diseases such as I/R, researchers speculated that scavenging excessive ROS might be a viable method for oxidative stress-related diseases in the future. 13,14 Nanozymes are inorganic nanomaterials that mimic enzyme activities. 15 Since ferromagnetic nanoparticles (NPs) were detected to possess enzyme-like activity for the first time, 16 various nanomaterials have been developed with peroxidase-like, oxidase-like, catalase-like and superoxide dismutase (SOD)-like activities and are widely used in biomedicine fields such as biosensing, disease diagnosis and treatment. 17,18 Furthermore, as Gao and Yan et al concluded, nanozymes should be consistent with the enzyme kinetics and catalytic mechanism of natural enzymes, such as the Michaelis–Menten equation. As a substitute for natural enzymes, even compared to other artificial enzymes, nanozymes are more prominent in their stability to pH and temperature, low production cost, ease of synthesis in large quantities, and reusability. 19,20 In addition, the unique physicochemical properties of nanomaterials endow them with a variety of functions and provide various methods for rational design. 21 -Abstract Truncated-

Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

ROS scavenging Mn3O4 nanozymes for in vivo anti-inflammation.

Ultrasmall Cu2O@His Nanozymes with RONS Scavenging Capability for Anti-inflammatory Therapy.

Self-Propelled Ultrasmall AuNPs-Tannic Acid Hybrid Nanozyme with ROS-Scavenging and Anti-Inflammatory Activity for Drug-Induced Liver Injury Alleviation.

Nanozymes Regulate Redox Homeostasis in ROS-Related Inflammation

Nanoparticles: A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity (adv. Sci. 10/2018)

Multi-enzymatic Activities of Ultrasmall Ruthenium Oxide for Anti-Inflammation and Neuroprotection

Twin defect-rich Pt ultrathin nanowire nanozymes alleviate inflammatory skin diseases by scavenging reactive oxygen species

Recent antioxidative nanomaterials toward wound dressing and disease treatment via ROS scavenging

Simultaneous Elimination of Reactive Oxygen Species and Activation of Nrf2 by Ultrasmall Nanoparticles to Relieve Acute Kidney Injury

Multi-shell nanocomposites based multienzyme mimetics for efficient intracellular antioxidation

Atomically Dispersed Cu Nanozyme with Intensive Ascorbate Peroxidase Mimic Activity Capable of Alleviating ROS‐Mediated Oxidation Damage

Nanozymes in the Treatment of Diseases Caused by Excessive Reactive Oxygen Specie

Porous selenium nanozymes targeted scavenging ROS synchronize therapy local inflammation and sepsis injury

Ultrasmall Ruthenium Nanoparticles with Boosted Antioxidant Activity Upregulate Regulatory T Cells for Highly Efficient Liver Injury Therapy

Integrating Pt Nanoparticles with Carbon Nanodots to Achieve Robust Cascade Superoxide Dismutase-Catalase Nanozyme for Antioxidant Therapy

Advances in metal-organic framework-based nanozymes in ROS scavenging medicine

Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy

Superoxide-like Cu/GO single-atom catalysts nanozyme with high specificity and activity for removing superoxide free radicals

Ultra‐Small Copper‐Based Multienzyme‐Like Nanoparticles Protect Against Hepatic Ischemia‐Reperfusion Injury Through Scavenging Reactive Oxygen Species in Mice